Boston Pharmaceuticals Widens Opportunities With New GSK Assets

Company In-Licenses Oncology, Neurology Drugs

 
• By Alaric DeArment
  
Business Growth Concept_1089895325_1200.jpg
Boston Pharmaceuticals has taken on two new assets under its 2018 deal with GlaxoSmithKline. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip